<DOC>
	<DOCNO>NCT01315158</DOCNO>
	<brief_summary>This randomize controlled trial compare rate sedation relate complication high risk patient ( ASA great equal 3 , BMI great equal 30 , risk OSA ) undergo advanced endoscopy procedure propofol alone compare propofol combination benzodiazepine opioids .</brief_summary>
	<brief_title>Propofol v Propofol + Benzo/Opiates High Risk Group</brief_title>
	<detailed_description>The use propofol ( 2,6-di-isopropofol ) sedation endoscopic procedure increase recent year primarily favorable pharmacokinetic profile compare traditional endoscopic sedation benzodiazepine opioids . Propofol rapid onset action ( 30-45 sec ) short duration effect ( 4-8 min ) . There also data support safe use propofol advance endoscopic procedure endoscopic retrograde cholangiopancreatography ( ERCP ) endoscopic ultrasound ( EUS ) . There limited information incidence sedation relate complication advance endoscopy . Prior study limit controlled patient population low risk develop sedation relate cardiopulmonary complication . In recent study , define frequency sedation related adverse event include rate airway modification ( AMs ) propofol use advance endoscopy . From total 799 patient , AMs require 14.4 % patient , hypoxemia 12.8 % , hypotension 0.5 % premature termination 0.6 % patient . In addition , body mass index ( BMI ) , male sex American Society Anesthesiologists ( ASA ) class 3 high independent predictor AMs . Similarly , Wehrmann Riphaus identify ASA class 3 high , total propofol dose , history alcohol use emergency endoscopy independent factor sedation relate complication patient undergo advanced procedure . Given alarm rate obesity United States , believe prevalence obstructive sleep apnea ( OSA ) may 10 % high obese adult number could high 25 % . Using previously validate screen tool OSA [ STOP-BANG ( SB ) ] , report prevalence rate patient risk OSA 43.3 % patient undergo advanced endoscopy procedure . Patients risk OSA positive SB score ( score â‰¥ 3 8 ) high rate AMs ( 20 % vs. 6.1 % , adjust relative risk 1.7 ) frequency hypoxemia ( 12 % vs. 5.2 % , adjust relative risk 1.63 ) compare low risk OSA . Thus , base available data , appear ASA class 3 high , high BMI , patient risk OSA factor place patient undergo advanced endoscopy procedure high risk sedation relate complication include airway modification . The optimal method achieve deep sedation high risk group patient unclear . Propofol may accentuate airway collapse patient become unresponsive verbal stimulation ( deep sedation ) . Recent study suggest propofol midazolam and/or opioids may synergistic action therefore combined application drug may permit small dos use potentially lead reduction risk complication dose propofol need retain individual advantage compound . There limited data evaluate synergistic effect propofol midazolam opioids patient undergo advanced endoscopy procedure . Ong colleague randomize controlled trial compare patient sedation tolerance ERCP use propofol alone midazolam , ketamine pentazocine ( sedato-analgesic cocktail ) induction along propofol maintenance . Patient tolerance assess visual analog scale endoscopist anesthetist high combination group . Paspatis et al report high dosage intravenous propofol require patient sedate propofol alone compare required patient receive oral dose midazolam propofol ERCP procedure . In addition , patient ' anxiety level procedure low combination group . The mean percentage decline oxygen saturation procedure significantly great propofol alone group . However , study exclude patient deem high risk sedation relate complication . Patients ASA class 3 high exclude , mean BMI le 25 , include patient average risk complication associate sedation . The significance synergistic sedation patient undergo advanced endoscopy procedure high risk patient unclear . The overall risk sedation relate complication think high compare standard endoscopy due long procedure time need relatively deep level sedation .</detailed_description>
	<mesh_term>Sleep Apnea Syndromes</mesh_term>
	<mesh_term>Sleep Apnea , Obstructive</mesh_term>
	<mesh_term>Propofol</mesh_term>
	<mesh_term>Midazolam</mesh_term>
	<mesh_term>Fentanyl</mesh_term>
	<mesh_term>Analgesics , Opioid</mesh_term>
	<criteria>Ability provide inform consent Age great equal 18 year Presence least 1 follow criterion : 1 . ASA class 3 high 2 . BMI 30 great 3 . At risk OSA ( score 3 great STOPBANG screen tool ) drug allergy Propofol , Benzodiazepines , Opioids patient receive Benzodiazepines Opioids within 24 hour procedure</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Obstructive Sleep Apnea</keyword>
	<keyword>Body Mass Index</keyword>
</DOC>